Granite Point Capital Management’s Altimmune ALT Stock Holding History

Granite Point Capital Management’s Portfolio ALT Stock Details ALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-180,000	Closed	-$2.3M	–	93
2022 Q3	$2.3M	Buy	+180,000	New	+$2.66M	0.93%	18
2020 Q4	–	Sell	-45,000	Closed	-$594K	–	151
2020 Q3	$594K	Sell	45,000 -105,000	-70%	-$2.1M	0.03%	135
2020 Q2	$1.61M	Buy	+150,000	New	+$824K	0.08%	94

Other funds holding ALT

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Granite Point Capital Management's ALT Position: Q4 2022 in Review

Granite Point Capital Management sold out of Altimmune (ALT) in Q4 2022, closing a stake of 180,000 shares — an estimated $2.3M sold.

Granite Point Capital Management first reported a position in ALT in Q2 2020 and held it in 3 quarters. The position peaked at $2.3M in Q3 2022. 128 funds tracked by Wall St. Rank hold ALT as of Q4 2022.

Granite Point Capital Management reported no remaining Altimmune position as of Q4 2022 after selling out during the quarter.
Granite Point Capital Management sold 180,000 Altimmune shares in Q4 2022, an estimated $2.3M.
Granite Point Capital Management first reported a position in Altimmune in Q2 2020 and held it in 3 quarters.
Granite Point Capital Management's Altimmune position peaked at $2.3M in Q3 2022.
128 funds tracked by Wall St. Rank held Altimmune as of Q4 2022.

Based on Granite Point Capital Management's 13F filing for Q4 2022, filed 7 Feb 2023.